Medical Condition News

RSS

Study offers new insight into the global obesity epidemic

Variation in consumption of market-acquired foods outside of the traditional diet -- but not in total calories burned daily -- is reliably related to indigenous Amazonian children's body fat, according to a Baylor University study that offers insight into the global obesity epidemic.

17 Jan 2021

Study sheds light on the causes of debilitating gut pain

A new study, published in the journal Nature, reports evidence from mice and humans that a novel mechanism contributes to chronic gut pain.

17 Jan 2021

Mothers of children with autism have many significantly different metabolite levels, study finds

Now, a study by researchers at the Rensselaer Polytechnic Institute, Arizona State University, and the Mayo Clinic found that mothers of children with autism spectrum disorder had several marked different metabolite levels two to five years after they gave birth compared to mothers of normally developing children.

17 Jan 2021

Scientists discover new treatment target for osteoarthritis-like knee cartilage degeneration

There is currently no cure for osteoarthritis, but a group of scientists believe they've discovered a method through which a simple knee injection could potentially stop the disease's effects.

16 Jan 2021

Study reveals significant role of ADAMTS1 protein in uveal melanoma

Scientists from the University of Granada and GENYO (Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research), in a study led by Juan Carlos Rodríguez-Manzaneque, have demonstrated the significant role of a protein called ADAMTS1 in uveal melanoma, one of the rarest and most aggressive cancers that exist, which develops in the eye.

15 Jan 2021

Patients with schizophrenia have increased risk of Parkinson's disease, shows study

A new study conducted at the University of Turku, Finland, shows that patients with a schizophrenia spectrum disorder have an increased risk of Parkinson's disease later in life.

15 Jan 2021

Religious beliefs modulate protein expression linked to cardiovascular disease in US South Asians

The Study on Stress, Spirituality and Health (SSSH), a cutting-edge proteomics analysis, suggests that religious beliefs modulate protein expression associated with cardiovascular disease in South Asians in the United States.

15 Jan 2021

Myelin‐specific T cells implicated in central nervous system disease in monkeys

Scientists have uncovered new clues implicating a type of herpes virus as the cause of a central nervous system disease in monkeys that's similar to multiple sclerosis in people.

15 Jan 2021

Special interests can potentially benefit individuals with autism

When he was in middle school, teachers would give Sam Curran a list of words to type in a computer to practice his vocabulary.

15 Jan 2021

Study to examine if changing mealtimes could reduce the risk of Type 2 diabetes

An innovative new study is set to examine if changing our mealtimes to earlier or later in the day could reduce the risk of developing Type 2 diabetes.

15 Jan 2021

Study shows why antihistamine drugs fail to control severe itch in eczema patients

In addition to a skin rash, many eczema sufferers also experience chronic itching, but sometimes that itching can become torturous. Worse, antihistamines -- the standard treatment for itching and allergy -- often don't help.

15 Jan 2021

Metformin drug decreases mortality rate in COVID-19 patients with type 2 diabetes

Use of the diabetes drug metformin -- before a diagnosis of COVID-19 -- is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham.

15 Jan 2021

Researchers to study potential treatment for limb dysfunction in patients with chronic spinal cord injury

Ghaith Androwis, PhD, and Steven Kirshblum, MD, received a grant from BrainQ Technologies to study a potential treatment for arm and hand dysfunction in individuals with chronic spinal cord injury.

15 Jan 2021

New drug reduces tumor volume and pain in patients with neurofibromatosis type 1

Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children's Hospital of Philadelphia (CHOP) as part of the Neurofibromatosis Clinical Trials Consortium have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1).

15 Jan 2021

Researchers use deep learning to study the effect of mental illness and other disorders on the brain

Compared to standard machine learning models, deep learning models are largely superior at discerning patterns and discriminative features in brain imaging, despite being more complex in their architecture, according to a new study in Nature Communications led by Georgia State University.

15 Jan 2021

Meniscal and mechanical symptoms do not predict findings on knee arthroscopy

Orthopaedic surgeons have traditionally been taught that certain types of knee symptoms indicate damage to specialized structures called the menisci.

15 Jan 2021

Study may help develop more effective personalized immunotherapy for cancer patients

New research from CU Cancer Center member Jing Hong Wang, MD, PhD, and recent University of Colorado Immunology program graduate Rachel Woolaver, PhD, may help researchers develop more effective personalized immunotherapy for cancer patients.

15 Jan 2021

Study reveals connection between oral sex and oropharyngeal cancer

A wide breadth of behaviors surrounding oral sex may affect the risk of oral HPV infection and of a virus-associated head and neck cancer that can be spread through this route, a new study led by researchers at the Johns Hopkins Kimmel Cancer Center suggests.

15 Jan 2021

New cancer models mimic aspects of mechanical environment within the body

As cancer and tumor cells move inside the human body, they impart and are subject to mechanical forces.

15 Jan 2021

Targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers

Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body's immune response.

15 Jan 2021

1
2
3
4
...
4469
Next

Medical Condition News

Study offers new insight into the global obesity epidemic

Study sheds light on the causes of debilitating gut pain

Mothers of children with autism have many significantly different metabolite levels, study finds

Scientists discover new treatment target for osteoarthritis-like knee cartilage degeneration

Study reveals significant role of ADAMTS1 protein in uveal melanoma

Patients with schizophrenia have increased risk of Parkinson's disease, shows study

Religious beliefs modulate protein expression linked to cardiovascular disease in US South Asians

Myelin‐specific T cells implicated in central nervous system disease in monkeys

Special interests can potentially benefit individuals with autism

Study to examine if changing mealtimes could reduce the risk of Type 2 diabetes

Study shows why antihistamine drugs fail to control severe itch in eczema patients

Metformin drug decreases mortality rate in COVID-19 patients with type 2 diabetes

Researchers to study potential treatment for limb dysfunction in patients with chronic spinal cord injury

New drug reduces tumor volume and pain in patients with neurofibromatosis type 1

Researchers use deep learning to study the effect of mental illness and other disorders on the brain

Meniscal and mechanical symptoms do not predict findings on knee arthroscopy

Study may help develop more effective personalized immunotherapy for cancer patients

Study reveals connection between oral sex and oropharyngeal cancer

New cancer models mimic aspects of mechanical environment within the body

Targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers

A paper-based sensor for detecting COVID-19

Cadmium linked to more severe flu and pneumonia infections

Could neurological complications be common even in mild COVID-19?

Latest News